Status:
TERMINATED
Metabolic Modulation as Treatment in Acute Heart Failure
Lead Sponsor:
University of Aarhus
Conditions:
Acute Heart Failure
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
The primary objective of this study is to evaluate whether metabolic modulation improves hemodynamics and outcome in acute heart failure
Detailed Description
Acute heart failure is a serious disease that despite modern therapies carries a high mortality. Inotropic drugs improve patient status but yield a higher risk of death. Previous studies have shown th...
Eligibility Criteria
Inclusion
- Acute heart failure
- NYHA class III - IV.
- ejection fraction \<35
Exclusion
- Age \<18 år or \>85 år,
- allergy
- renal failure
- recently developed brady- or tachy-arrythmias
- Serious infection
- Heart failure due to restrictive or hypertrophic cardiomyopathy or stenotic valvular heart disease
- Recent Myocardial infarction (\<6 Weeks)
- Pulmonary Wedge pressure \>30 mm Hg
- diabetes mellitus treated with insulin
- peptic ulcer
- pregnancy
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2007
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00449423
Start Date
March 1 2007
End Date
October 1 2007
Last Update
October 25 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital, Skejby Sygehus, Department of Cardiology
Aarhus, Aarhus, Denmark, 8200